Xuankai Biological Technology closes RMB80m Series B

Xuankai Biological Technology has recently announced the completion of its Series B financing round worth 80 million yuan. The round was led by Wens and Jinyu Maowu Investment, with participation from Nanjing Innovation Capital Group.

Xuankai Biological Technology has recently announced the completion of its Series B financing round worth 80 million yuan. The round was led by Wens and Jinyu Maowu Investment, with participation from Nanjing Innovation Capital Group.

Proceeds from this round of financing will be mainly used for the company’s new Chuzhou industrial base construction, sales channel construction and new product development.

Xuankai Biological Technology is a Chinese biotechnology R&D, manufacturing and service company.With the tenet of “using biotechnology to solve agricultural problems”, the company conducts research, development and production of core raw materials on three platforms: functional microorganisms, microbial secretions and enzyme catalysis and conversion.

The company focuses on the development of products in the three major application areas of “plant nutrition and health, animal nutrition and health, and cosmetics”, forming a closed loop from research and development to industrialization.

Feng Xiaohai, general manager ofXuankai Biological Technology, said that in the future, the company will use biotechnology to lead China’s quality agriculture, and further strengthen its investment in the plant nutrition segment and cosmetics.

It will also join hands with partners such as Wens, to enter the feed and aquatic sectors.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/08/02/xuankai-biological-technology-closes-rmb80m-series-b/.

Leave a Reply

Please Login to Comment